CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

Simone Weber, Victoria Kehl, Johanna Erber, Karolin I. Wagner, Ana-Marija Jetzlsperger, Theresa Burrell, Kilian Schober, Philipp Schommers, Max Augustin, Claudia S. Crowell, Markus Gerhard, Christof Winter, Christoph D. Spinner, Ulrike Protzer, Dieter Hoffmann, Elvira D’Ippolito, Dirk H Busch
doi: https://doi.org/10.1101/2021.12.22.21268268

Article usage

Article usage: December 2021 to December 2024

AbstractFullPdf
Dec 202113241260
Jan 2022170885
Feb 202268043
Mar 202250522
Apr 202247217
May 202248121
Jun 202247019
Jul 20224522
Aug 20223038
Sep 202245111
Oct 20223106
Nov 20222009
Dec 20222439
Jan 20231806
Feb 202328211
Mar 20231913
Apr 20231722
May 20231525
Jun 2023855
Jul 2023715
Aug 2023181111
Sep 20231465
Oct 20231412
Nov 20231261
Dec 20231326
Jan 2024955
Feb 20242656
Mar 2024655
Apr 20241195
May 2024916
Jun 20241476
Jul 2024989
Aug 20242369
Sep 20241457
Oct 2024998
Nov 202416317
Dec 2024001
Back to top
Posted December 24, 2021.
Download PDF
Data/Code
Email
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
Simone Weber, Victoria Kehl, Johanna Erber, Karolin I. Wagner, Ana-Marija Jetzlsperger, Theresa Burrell, Kilian Schober, Philipp Schommers, Max Augustin, Claudia S. Crowell, Markus Gerhard, Christof Winter, Christoph D. Spinner, Ulrike Protzer, Dieter Hoffmann, Elvira D’Ippolito, Dirk H Busch
medRxiv 2021.12.22.21268268; doi: https://doi.org/10.1101/2021.12.22.21268268
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area